Correction to: Significance of targeting DNMT3A mutations in AML [0.03%]
Correction to："靶向DNMT3A突变在AML治疗中的意义"
Guiqin Huang,Xiaoya Cai,Dengju Li
Guiqin Huang
Published Erratum
Annals of hematology. 2026 Mar 13;105(4):175. DOI:10.1007/s00277-026-06929-x 2026
Prognostic significance of CUX1 genomic deletion in myelodysplastic neoplasms [0.03%]
CUX1基因缺失在骨髓增生异常肿瘤中的预后意义
Mohamed M Khamis,Aleksandar Babic,Aref Al-Kali et al.
Mohamed M Khamis et al.
Background: Molecular profiling has transformed risk stratification in myelodysplastic neoplasms (MDS). However, the independent prognostic value of specific genomic alterations beyond comprehensive molecular scoring rema...
Epidemiology, treatment patterns, and survival outcomes of patients with mantle cell lymphoma in Germany: a retrospective analysis of administrative claims data [0.03%]
德国 Mantle Cell 淋巴瘤患者的流行病学、治疗模式和预后结局：基于管理式医疗索赔数据的回顾性分析
Heiko Friedel,Nora Hennies,Jürgen Zschocke et al.
Heiko Friedel et al.
Until the early 2020s, standard mantle cell lymphoma (MCL) treatment in Germany primarily included chemoimmunotherapy, autologous stem cell transplantation (autoSCT) for eligible patients in first line, and covalent Bruton tyrosine kinase i...
Observational Study
Annals of hematology. 2026 Mar 13;105(4):173. DOI:10.1007/s00277-026-06915-3 2026
Talquetamab induces deep responses in heavily pre-treated patients with systemic light-chain amyloidosis [0.03%]
Talquetamab诱导他克莫司重预处理系统性轻链淀粉样变患者产生深度应答
Tamir Shragai,Muhammad Ganayem,Yael C Cohen et al.
Tamir Shragai et al.
Clonal analysis of a case with fluid overload-associated large B-cell lymphoma evolving from primary large B-cell lymphoma of the central nervous system [0.03%]
一例中枢神经系统原发性大B细胞淋巴瘤转化来的与体液超负荷相关的弥漫型大B细胞淋巴瘤的克隆分析
Yuta Ito,Yasunori Kogure,Akiko Miyagi Maeshima et al.
Yuta Ito et al.
A 62-year-old female was referred to our hospital because of left pleural effusion. She had a history of primary large B-cell lymphoma (LBCL) of the CNS (PCNSL), which was treated with chemoradiotherapy 14 years ago. Imaging studies reveale...
Successful allogeneic stem cell transplant in a patient with a left ventricular assist device: a novel case report [0.03%]
左心室辅助装置患者成功进行同种异体干细胞移植的一个新颖病例报告
Kevin G Zablonski,Umar Sabir,Jason H Mendler et al.
Kevin G Zablonski et al.
Historically, severe heart failure has been considered a contraindication for hematopoietic stem cell transplant (HSCT). Despite the growing use of the left ventricular assist device (LVAD), clinicians have avoided HSCT in patients with hem...
Inhibition of CDC20 suppresses the development and progression of mantle cell lymphoma through PI3K/AKT pathway [0.03%]
CDC20抑制通过PI3K/AKT途径抑制套细胞淋巴瘤的发展和进展
Yingtong Chen,Ping Yang,Shuang Gao et al.
Yingtong Chen et al.
Cell division cycle 20 homologue (CDC20), a key regulator of mitosis, is frequently overexpressed in cancers and linked to tumor progression. However, its role in mantle cell lymphoma (MCL) remains unclear. This study explored the functiona...
The prognostic impact of myeloid co-mutation burden in TP53-mutated AML/MDS after allogeneic stem cell transplantation: a multicenter retrospective analysis [0.03%]
TP53突变的急性髓系白血病和骨髓增生异常综合征异基因干细胞移植后的髓系伴随突变负荷对其预后的影响：多中心回顾性分析
Yao Sun,Shanshan Qin,Lu Wang et al.
Yao Sun et al.
TP53 mutations are associated with poor prognosis in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Allogeneic hematopoietic stem cell transplantation (allo-HSCT) offers a potential cure, but outcomes are suboptimal and r...
Multicenter Study
Annals of hematology. 2026 Mar 7;105(4):168. DOI:10.1007/s00277-026-06895-4 2026
Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China [0.03%]
中国套细胞淋巴瘤病人的临床特点和预后因素的真实世界研究：分裂型和多形型变异亚型分析
Ying Huang,Xiang Zhang,Yunfei Lv et al.
Ying Huang et al.
Blastoid and pleomorphic mantle cell lymphoma (B/P-MCL) represents a high-risk subtype of hematological malignancy with an unfavorable prognosis. We conducted a retrospective analysis of 76 patients with classic MCL and 81 patients with B/P...
Risk factors for venous thromboembolism in newly diagnosed multiple myeloma patients based on thrombosis prophylaxis [0.03%]
基于抗凝预防的多发性骨髓瘤诊断患者静脉血栓栓塞的风险因素分析
Sen Zhao,Yini Wang,Jing Jia et al.
Sen Zhao et al.
This study aimed to explore risk factors for symptomatic venous thromboembolism (VTE) in newly diagnosed multiple myeloma (NDMM) patients, with particular focus on the moderating effect of age. A retrospective case-control study was conduct...